Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 206
Filtrar
1.
Dermatol Surg ; 50(9): 847-850, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38722745

RESUMO

BACKGROUND: Chemical reconstruction of skin scars (CROSS) using high concentration trichloroacetic acid (TCA) is a safe, effective, and low-cost treatment for ice pick acne scars. OBJECTIVE: To compare the efficacy and effectiveness of the CROSS technique using 50% TCA and 80% TCA for treating ice pick scars. MATERIALS AND METHODS: A nonrandomized, single-blinded, and self-controlled clinical trial was undertaken. Four CROSS sessions were conducted using 50% TCA on the left hemiface and 80% TCA on the right hemiface. The E' chelle d'Evaluation Clinique des Cicatrices d'Acne (ECCA) acne grading scale was used to assess the scars pretreatment and posttreatment. Complications were evaluated after each session. RESULTS: Thirty-one patients participated in our study. Significant differences were found between pretreatment and posttreatment ECCA scores ( p < .0001) on both hemifaces. Scores were significantly lower on the side treated with 80% TCA; however, there was no statistical significance in mean ECCA score differences (pretreatment minus posttreatment) between the 2 treatment sides. The adverse events were more serious on the sides treated with 80% TCA. CONCLUSION: The CROSS method using TCA was well-tolerated and effective for treating ice pick acne scars. Less severe complications were associated with 50% TCA, whereas efficacy was the same as 80% TCA.


Assuntos
Acne Vulgar , Cáusticos , Cicatriz , Ácido Tricloroacético , Humanos , Ácido Tricloroacético/administração & dosagem , Ácido Tricloroacético/efeitos adversos , Acne Vulgar/complicações , Acne Vulgar/tratamento farmacológico , Cicatriz/etiologia , Cicatriz/terapia , Cicatriz/tratamento farmacológico , Feminino , Masculino , Adulto , Cáusticos/administração & dosagem , Método Simples-Cego , Adulto Jovem , Resultado do Tratamento , Adolescente
3.
Dermatol Surg ; 50(5): 467-470, 2024 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-38460193

RESUMO

BACKGROUND: Improving the appearance of lentigines on the hands is a key component to hand rejuvenation. Soft tissue fillers revolumize hands, but do not address pigmentary changes. OBJECTIVE: This study investigated the effiacy of a 15% trichloroacetic acid (TCA) + 3% glycolic acid (GA) combination peel in improvement of appearance of hand lentigines. METHODS: A prospective evaluator-blinded, split-hand study was performed using a 15% TCA + 3% GA peel to treat patients with hand lentigines. Subjects received a total of 3 treatments at 4-week intervals on 1 hand, with the other hand serving as an untreated control. Final photographs were taken 12 weeks after the last treatment. Two blinded board-certified dermatologists graded improvement in hand lentigines using a 5-point scale. RESULTS: Eighteen of 20 patients completed the study (90%). The mean age was 64.4 years (SE 1.6, range 51-71). The mean pain scores were 3.8 (SE 0.4) on a 10-point scale (1 = no pain, 10 = extremely painful). Blinded evaluators correctly identified the after-treatment photographs in 16 patients (88%). Physician and patient-graded mean improvement of lentigines was significant for treated versus control hands ( p < .01). No adverse events were noted. CONCLUSION: A series of three 15% TCA + 3% GA peels are effective and safe in the treatment of hand lentigines.


Assuntos
Abrasão Química , Glicolatos , Ácido Tricloroacético , Humanos , Ácido Tricloroacético/administração & dosagem , Ácido Tricloroacético/efeitos adversos , Glicolatos/administração & dosagem , Pessoa de Meia-Idade , Abrasão Química/métodos , Estudos Prospectivos , Idoso , Feminino , Masculino , Lentigo/tratamento farmacológico , Método Simples-Cego , Mãos , Ceratolíticos/administração & dosagem , Resultado do Tratamento
5.
Khirurgiia (Mosk) ; (1): 22-26, 2021.
Artigo em Russo | MEDLINE | ID: mdl-33395508

RESUMO

OBJECTIVE: To compare the efficacy of chemical pleurodesis with talc and trichloroacetic acid during thoracoscopy. MATERIAL AND METHODS: Thoracoscopy with pleural biopsy was performed in 355 (83.5%) out of 424 patients with pleural effusion. Pleurodesis was ensured by intraoperative insufflation of talc powder (n=135) and application of 33% trichloroacetic acid solution to parietal and visceral pleura (n=19) in patients with malignant (125), inflammatory (6), post-traumatic (4), tuberculous (3), pancreatogenic (8) and hepatogenic (8) effusions. Drainage tubes were removed if daily drainage output volume was less than 100 ml or complete lung inflation was observed. RESULTS: Post-pleurodesis drainage took 7.1±5.4 days. Two patients developed bumpy rashes that were initially interpreted as carcinomatosis. However, these rashes were later identified as tuberculosis. Retrospectively, these patients were not good candidates for pleurodesis. Pleurodesis with talc suppressed exudation in 89.6% of cases. Complications developed in 4 cases (3%): pneumonia (1) and pleural empyema (3). These complications were associated with a violation of technical procedure of pleurodesis, i.e. procedure in rigid lung, atelectasis (1) and bronchopleural fistula (2). Mean duration of drainage after trichloroacetic acid-induced pleurodesis was 7.9±6.7 days. This procedure was effective in 84.2% of cases, and there were no complications. There are no previous reports on the use of this pleurodesis technique in the literature. Mean duration of drainage after talc-induced pleurodesis was decreased up to 6.9±5.4 days in patients with malignant pleural effusion (p<0.05), after trichloroacetic acid-induced pleurodesis - up to 7.5±8.1 days (p>0.05) compared to patients without pleurodesis (9.1±11.2 days). CONCLUSION: Pleurodesis with talc or trichloroacetic acid during thoracoscopy is effective for pleural effusions following malignancies, liver, kidney and cardiac diseases with decompensation. Essential requirements are adequate lung inflation, no atelectasis and bronchopleural fistula.


Assuntos
Derrame Pleural , Pleurisia , Pleurodese/métodos , Soluções Esclerosantes , Talco , Ácido Tricloroacético , Administração Tópica , Exsudatos e Transudatos , Humanos , Derrame Pleural/diagnóstico , Derrame Pleural/etiologia , Derrame Pleural/terapia , Pleurisia/etiologia , Pleurisia/terapia , Estudos Retrospectivos , Soluções Esclerosantes/administração & dosagem , Soluções Esclerosantes/efeitos adversos , Talco/administração & dosagem , Talco/efeitos adversos , Toracoscopia , Ácido Tricloroacético/administração & dosagem , Ácido Tricloroacético/efeitos adversos
6.
Dermatol Surg ; 47(2): e53-e57, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-32826599

RESUMO

BACKGROUND: Despite the recent advances in the treatment of vitiligo, results are still largely unsatisfactory and many patients show either weak or no response to treatment. Few clinical trials have investigated the use of trichloroacetic acid (TCA) to induce repigmentation in stable vitiligo. OBJECTIVE: To evaluate the efficacy and safety of TCA, in different concentrations, for the treatment of stable localized vitiligo. METHODS: The study included 100 patients with acral/nonacral stable vitiligo. Trichloroacetic acid was applied, as a monotherapy, to the vitiliginous patches at different concentrations according to the treated site every 2 weeks until complete repigmentation or for a maximum of 6 treatment sessions. Follow-up was done every month for 6 months to detect any recurrence. RESULTS: Eyelid vitiligo showed the highest response to TCA treatment (excellent response in 80% of cases), followed by the face, trunk, and extremities. Lower response rates were noticed in the hands and feet vitiligo. Adverse effects were transient and insignificant in few patients. CONCLUSION: Trichloroacetic acid seems to be a potential, cost-effective, well-tolerated therapeutic option for the treatment of vitiligo in the adults and pediatric populations.


Assuntos
Ácido Tricloroacético/administração & dosagem , Vitiligo/tratamento farmacológico , Administração Cutânea , Adolescente , Adulto , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva , Pigmentação da Pele/efeitos dos fármacos , Resultado do Tratamento , Ácido Tricloroacético/efeitos adversos , Adulto Jovem
7.
Arch Iran Med ; 23(11): 740-748, 2020 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-33220690

RESUMO

BACKGROUND: In Iran, zoonotic and anthroponotic cutaneous leishmaniasis (CL) are caused by Leishmania major and L. tropica respectively. Despite extensive studies, no effective therapies have ever been reported for CL. The main objective of this research was to determine and compare the three different protocols for treatment of CL patients referring to Skin Diseases and Leishmaniasis Research Center (SDLRC), affiliated to Isfahan University of Medical Sciences, Isfahan, Iran from September 2017 to October 2018. METHODS: In a randomized controlled parallel groups clinical trial, 150 selected CL patients who met our inclusion criteria were randomly assigned to one of the three therapy groups: A, intra-lesional glucantime plus 50% trichloroacetic acid (TCA), B, intralesional glucantime and C, systemic glucantime. All patients in the three groups received the complete course of treatment and were followed for 6 months. To identify the etiologic agents, smears from their lesions were prepared and PCR-RFLP was used after parasite culture. Also, clinical characteristics, history of previous involvement, endemic emigration and demographic data were collected. RESULTS: The results showed that the mean value of healing period was 53.12 ± 25.88 (median: 45, IQR: Q1 = 30-Q3 = 77) days in group A, 57.22 ± 44.02 (median: 42.5, IQR: Q1 = 30-Q3 = 60) days in group B, and 73.56 ± 41.08 (median: 71, IQR: Q1 = 45-Q3 = 90) days in group C; the observed differences were statistically significant (P=0.024). There was a significant difference between group A and group C (P = 0.049), and between group B and group C (P = 0.047) in terms of mean healing period. Finally, complete recovery rates of 80%, 62% and 42% were shown in the three medicinal groups of A, B and C, respectively (P = 0.022). CONCLUSION: In this study, the average duration of lesion healing among the three groups was the shortest in patients with IL glucantime plus 50% TCA treatment regimen. Also, the use of 50% TCA in patients suffering from CL was associated with a significant improvement in the depth of scars, the time and the percentage of recovery, and the low cost of this agent in the treatment of CL.


Assuntos
Antiprotozoários/administração & dosagem , Cáusticos/administração & dosagem , Leishmaniose Cutânea/tratamento farmacológico , Antimoniato de Meglumina/administração & dosagem , Ácido Tricloroacético/administração & dosagem , Adolescente , Adulto , Quimioterapia Combinada , Feminino , Humanos , Irã (Geográfico) , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem
8.
Arch Dermatol Res ; 312(10): 725-730, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32253506

RESUMO

Postinflammatory hyperpigmentation (PIH) occurs following cutaneous injury and is common following resolution of acne especially in patients with skin of color. The objective of this study was to further validate a trichloroacetic acid (TCA)-induced PIH model and compare it to acne-induced PIH using topical bakuchiol, a botanical extract that has been shown to have antimicrobial, anti-inflammatory, antioxidant, and antiacne properties. A prospective, non-randomized clinical trial was conducted on subjects with skin phototypes IV-VI with a history of acne-induced PIH. Subjects applied bakuchiol or vehicle cream twice daily to 2 acne-induced and 2 TCA-induced PIH lesions for 28 days with a third lesion serving as a control in each group. Degree of improvement was defined as the change in the Investigator Global Assessment (IGA) score over 28 days of treatment. Twenty subjects (6 males, 14 females) completed the study. For TCA-induced PIH sites, there was a statistically significant (p < 0.05) degree of improvement with bakuchiol treatment (- 0.50 ± 0.18) compared to vehicle (0.05 ± 0.15) and control (- 0.06 ± 0.17). For acne-induced PIH, there was a greater degree of improvement for bakuchiol (- 1.06 ± 0.23) when compared to vehicle (- 0.56 ± 0.16) and control (- 0.69 ± 0.18); however, statistical significance was not reached (p > 0.05). TCA-induced PIH sites were uniform in size and pigment intensity thereby allowing better comparison among sites. This emphasizes the relevance of using this model for PIH which may help reduce the barriers in clinical trials and help improve access to treatments for patients who suffer from PIH. The results suggest that topical bakuchiol may decrease the severity of PIH.


Assuntos
Acne Vulgar/complicações , Hiperpigmentação/tratamento farmacológico , Inflamação/complicações , Fenóis/administração & dosagem , Ácido Tricloroacético/imunologia , Acne Vulgar/imunologia , Adolescente , Feminino , Seguimentos , Humanos , Hiperpigmentação/diagnóstico , Hiperpigmentação/imunologia , Inflamação/induzido quimicamente , Inflamação/imunologia , Masculino , Estudos Prospectivos , Índice de Gravidade de Doença , Pele/efeitos dos fármacos , Pele/imunologia , Creme para a Pele/administração & dosagem , Pigmentação da Pele/efeitos dos fármacos , Pigmentação da Pele/imunologia , Resultado do Tratamento , Ácido Tricloroacético/administração & dosagem , Adulto Jovem
9.
Ann Dermatol Venereol ; 147(4): 293-297, 2020 Apr.
Artigo em Francês | MEDLINE | ID: mdl-32164922

RESUMO

BACKGROUND: Verrucous or hypertrophic lichen planus is a chronic inflammatory skin disease characterized by extremely pruritic thick hyperkeratotic plaques and is resistant to topical treatment. PATIENTS AND METHODS: Herein, we report three clinical cases of hypertrophic lichen planus successfully treated with a combination of topical steroids daily in occlusion and trichloroacetic acid (TCA) 50% with peeling every week. DISCUSSION: TCA is involved in regulating inflammation and scarring. Through its keratolytic properties it enhances the efficacy of topical steroids, whose action is hindered by hyperkeratosis. CONCLUSION: The combination of TCA and topical steroids offers a good alternative for the treatment of hypertrophic lichen planus.


Assuntos
Anti-Inflamatórios/uso terapêutico , Clobetasol/uso terapêutico , Ceratolíticos/uso terapêutico , Líquen Plano/tratamento farmacológico , Ácido Tricloroacético/uso terapêutico , Idoso de 80 Anos ou mais , Anti-Inflamatórios/administração & dosagem , Clobetasol/administração & dosagem , Quimioterapia Combinada , Feminino , Humanos , Hipertrofia , Ceratolíticos/administração & dosagem , Masculino , Pessoa de Meia-Idade , Prurido/etiologia , Ácido Tricloroacético/administração & dosagem
10.
Pan Afr Med J ; 37: 98, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33425131

RESUMO

Seborrheic keratoses (SKs) are benign tumor of the skin. They can occur anywhere, except the palms and soles. SKs commonly present as multiple, pigmented papules which is classically described as verrucous stuck-on papules or plaques. A case with multiple nodular appearance is a rare case and to our knowledge has never been reported. Here we report a rare case of multiple SKs on the scalp. On clinical evaluation, multiple, erythematous hyperkeratotic nodules were present. Dermoscopic and histopathological examination supported SKs. The patient was successfully treated with topical application of 80% TCA solution.


Assuntos
Fármacos Dermatológicos/administração & dosagem , Ceratose Seborreica/diagnóstico , Couro Cabeludo/patologia , Ácido Tricloroacético/administração & dosagem , Administração Cutânea , Adulto , Dermoscopia , Humanos , Ceratose Seborreica/tratamento farmacológico , Masculino , Resultado do Tratamento
12.
Orbit ; 39(2): 107-111, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31282238

RESUMO

Purpose: To evaluate the effect of intra-lesional injection of Trichloroacetic acid (TCA) 10% in patients with conjunctival inclusion cysts.Methods: This prospective case series study included all patients with conjunctival inclusion cyst who were referred to our referral center from August 2016 to August 2018. All patients received TCA 10% injection into the conjunctival cyst, and outcomes of the intervention were evaluated at least 6 months later.Results: Ten patients with mean age of 24 ± 17.6 (range 6-65) years including three children received TCA 10% injection into the conjunctival cyst. We included 6 anophthalmic and 4 ophthalmic cases. All patients were treated successfully and no recurrence of the lesion was observed in any case. Mean follow up duration was 18.1 ± 8.3 (range 6-28) months.Conclusion: Intra-lesional injection of TCA 10% is a safe, simple, and effective treatment in patients with conjunctival inclusion cysts including ophthalmic cases and anophthalmic cases, both in adults and in children. This concentration may avoid ocular surface complications.


Assuntos
Cáusticos/uso terapêutico , Doenças da Túnica Conjuntiva/tratamento farmacológico , Cistos/tratamento farmacológico , Ácido Tricloroacético/uso terapêutico , Adolescente , Adulto , Idoso , Cáusticos/administração & dosagem , Criança , Feminino , Humanos , Injeções Intraoculares , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ácido Tricloroacético/administração & dosagem
14.
J Cosmet Dermatol ; 19(6): 1517-1521, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31638311

RESUMO

BACKGROUND: Therapies for postacne scarring act through modulation of elastin and collagen, and collagen III might therefore represent a biomarker of treatment effectiveness. PATIENTS AND METHODS: Patients (n = 70) with postacne scars and individuals without scars (n = 56) were included in this case-control study. Patients were treated with Dermaroller microneedling, trichloroacetic acid chemical reconstruction, punch excision, or scar subcision. Scar severity was graded immediately before and after treatment with a photographic quartile scale and the ECCA scale. Serum levels of collagen III were measured in control individuals and in patients, before treatment, 1 month after the first treatment session, and 4 months after the final session. RESULTS: Circulating levels of collagen III were significantly higher in patients with postacne scarring (24.1 ± 12.5) before treatment than in control individuals (2.6 ± 0.8). Circulating levels of collagen in patients were significantly lower 4 months posttreatment (14.3 ± 8.1) than at baseline. The mean percentage change in serum collagen III was positively correlated with both the mean percentage improvement by photographic evaluation (r = .530, P < .000) and the mean percentage change in the ECCA scale (r = .632, P < .000). CONCLUSION: Circulating collagen III is a biomarker for improvement of postacne scarring following different therapies.


Assuntos
Acne Vulgar/terapia , Cicatriz/terapia , Colágeno Tipo III/sangue , Pele/patologia , Acne Vulgar/complicações , Adolescente , Adulto , Biomarcadores/sangue , Estudos de Casos e Controles , Cáusticos/administração & dosagem , Cicatriz/sangue , Cicatriz/diagnóstico , Cicatriz/etiologia , Colágeno Tipo III/metabolismo , Agulhamento Seco , Feminino , Humanos , Hipertrofia/diagnóstico , Hipertrofia/etiologia , Hipertrofia/terapia , Masculino , Fotografação , Índice de Gravidade de Doença , Pele/diagnóstico por imagem , Pele/efeitos dos fármacos , Pele/metabolismo , Resultado do Tratamento , Ácido Tricloroacético/administração & dosagem , Adulto Jovem
15.
J Cosmet Dermatol ; 19(6): 1367-1370, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31638316

RESUMO

BACKGROUND: Cutaneous leishmaniasis (CL) is an endemic disease of Iran and despite self-healing nature of this disease and many suggested treatments, scar is usually inevitable results of the affection with this cutaneous infection. CO2 laser in CL has a specific thermolysis effect on infected tissues and application of trichloroacetic acid (TCA) 50% solution for treatment of leishmaniasis scars showed promising results. AIM: To evaluate CO2 laser plus TCA 50% versus CO2 laser alone for treatment of CL. PATIENTS/METHODS: In the current report, we present 6 cases of noduloulcerative CL that were treated successfully by the combination of the continuous wave CO2 laser plus topical application of TCA 50%. RESULTS: Five patients improved after 3 weeks of starting treatment, and 1 patient needed to repeat treatment. The scars were flat and good. CONCLUSIONS: The CO2 laser plus topical TCA 50% may be more effective in treatment of the cutaneous leishmaniasis and results in shorter healing time.


Assuntos
Cáusticos/administração & dosagem , Cicatriz/terapia , Lasers de Gás/uso terapêutico , Leishmaniose Cutânea/terapia , Ácido Tricloroacético/administração & dosagem , Administração Cutânea , Adolescente , Adulto , Criança , Pré-Escolar , Cicatriz/etiologia , Feminino , Humanos , Irã (Geográfico) , Leishmaniose Cutânea/complicações , Masculino , Fatores de Tempo , Resultado do Tratamento , Cicatrização/efeitos dos fármacos , Cicatrização/efeitos da radiação
16.
J Cosmet Dermatol ; 19(1): 137-146, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31603267

RESUMO

BACKGROUND: Photoaging (extrinsic aging) is caused by environmental exposure to ultraviolet radiation. Superficial and medium-depth chemical peels with trichloroacetic acid (TCA) are performed to reduce wrinkles, hyperpigmentation, dryness, and erythema caused by photoaging process. AIM: The aim of this study was to compare the efficacy and tolerability of 15% TCA peel against the combined 70% glycolic acid and 35% TCA for the treatment of photodamaged facial skin. PATIENTS/METHODS: Forty female patients with types II and III of Glogau photoaging scale were divided into two groups of twenty subjects (GA/TCA and 35% TCA). The GA/TCA group was treated with combination peeling of 70% GA and 15% TCA, whereas the 35% TCA group was treated with monopeeling of 35% trichloroacetic acid. Each patient was submitted to five sessions of these peels, with an interval of 14 days between each session. The following skin aging parameters were examined before treatments, before each session, and 3 months after the last application: hydration, elasticity, melanin index, and erythema index (MPA-5; Courage-Khazaka, Germany); and depth and volume of wrinkles (PRIMOS; GFMesstechnik GmbH, Germany). RESULTS: Both peel methods achieved significant improvement in all skin parameters: elasticity, hydration, melanin index, and erythema index. Significant differences between the GA/TCA and 35% TCA groups were found only for hydration and melanin index. GA/TCA was characterized by significantly higher values of the hydration parameter and lower values of melanin index compared with 35% TCA. Combination peel GA/TCA did not cause dryness, edema, or intensive lysis of the epidermis, and the frequency of peel-induced erythema did not increase with the addition of glycolic acid, but with higher concentration of the TCA solution. However, subject-perceived improvements of the 35% TCA peel did not differ significantly from subject-perceived improvements of combination peel treatment. Adverse events requiring intervention or discontinuing treatment were not observed in either group. CONCLUSION: The addition of glycolic acid before 15% TCA chemical peel application significantly enhanced TCA-induced improvement in photoaging parameters (increase in skin elasticity and hydration; reduction in melanin index and erythema index), and subject-perceived improvements. However, 35% TCA peel is more effective in reducing wrinkles, despite a lower tolerability. Both medium-depth chemical peels including 15% TCA in combination with 70% GA and 35% TCA alone proved to be useful for the removal of epidermal or superficial lesions and to improve the texture of photodamaged facial skin (grade II-III Glogau photoaged skin).


Assuntos
Cáusticos/administração & dosagem , Abrasão Química/métodos , Glicolatos/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Ácido Tricloroacético/administração & dosagem , Administração Cutânea , Adulto , Cáusticos/efeitos adversos , Abrasão Química/efeitos adversos , Relação Dose-Resposta a Droga , Face , Feminino , Glicolatos/efeitos adversos , Humanos , Pessoa de Meia-Idade , Medição da Dor , Dor Processual/diagnóstico , Dor Processual/etiologia , Envelhecimento da Pele/efeitos da radiação , Resultado do Tratamento , Ácido Tricloroacético/efeitos adversos , Raios Ultravioleta/efeitos adversos
17.
J Drugs Dermatol ; 18(9): 957-959, 2019 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-31524998

RESUMO

Man has tried and sought to erase wrinkles and scars for millennia. Sadly, however, the most effective and permanent techniques have fallen into disuse and neglect due to lack of training in universities, lack of awareness on the part of both physicians and patients, and heavy mass marketing of injectable fillers. Dermal grafting is a standard, time honored method for permanent correction of deep facial defects. Our goal as dermatologists is to generate the best results for our patients, and also to develop our personal skills and talents to the utmost.


Assuntos
Cicatriz/cirurgia , Técnicas Cosméticas , Derme/transplante , Envelhecimento da Pele/efeitos dos fármacos , Transplante de Pele/métodos , Cicatriz/tratamento farmacológico , Preenchedores Dérmicos/administração & dosagem , Preenchedores Dérmicos/efeitos adversos , Humanos , Injeções Intralesionais , Masculino , Ácido Tricloroacético/administração & dosagem , Ácido Tricloroacético/efeitos adversos
18.
Dermatol Surg ; 45(11): 1394-1400, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31464703

RESUMO

BACKGROUND: To study and compare the therapeutic efficacy and side effects of a 35% glycolic acid (GA) full face peel alone or in combination with a 10% or 20% trichloroacetic acid (TCA) spot peel for facial melasma. METHODS: Thirty patients with facial melasma were randomly divided into 3 equal Groups A, B, and C. Group A was treated with a 35% GA full-face peel, Group B and C with 35% GA full-face peel followed by a 10% and 20% TCA spot peel respectively once every 15 days. Four peels were performed once every 15 days. The response to the treatment was evaluated by the percentage reduction in melasma area severity index (MASI) scoring. RESULTS: All 3 groups had significant reduction of MASI, but there was no significant difference between the groups. Group A had minimum side effects. CONCLUSION: Chemical peels with GA alone or in combination with TCA do result in a significant improvement in melasma, but the combination of the peels in the same sitting does not seem to have any additive or synergistic effect while they may increase the side effects.


Assuntos
Abrasão Química/métodos , Glicolatos/administração & dosagem , Ceratolíticos/administração & dosagem , Melanose/terapia , Ácido Tricloroacético/administração & dosagem , Adulto , Abrasão Química/efeitos adversos , Terapia Combinada , Face , Feminino , Glicolatos/efeitos adversos , Humanos , Ceratolíticos/efeitos adversos , Masculino , Pessoa de Meia-Idade , Pele/efeitos dos fármacos , Resultado do Tratamento , Ácido Tricloroacético/efeitos adversos , Adulto Jovem
20.
J Cosmet Dermatol ; 18(6): 1680-1685, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31021041

RESUMO

BACKGROUND: Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. OBJECTIVE: This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH. SUBJECTS AND METHODS: Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. RESULTS: Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). CONCLUSIONS: Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.


Assuntos
Transfusão de Sangue Autóloga/métodos , Cáusticos/administração & dosagem , Abrasão Química/métodos , Hiperpigmentação/terapia , Plasma Rico em Plaquetas , Administração Cutânea , Adulto , Transfusão de Sangue Autóloga/efeitos adversos , Cáusticos/efeitos adversos , Bochecha , Abrasão Química/efeitos adversos , Feminino , Humanos , Hiperpigmentação/diagnóstico , Injeções Intradérmicas , Ácido Láctico/administração & dosagem , Ácido Láctico/efeitos adversos , Masculino , Microinjeções , Satisfação do Paciente , Fotografação , Pele/diagnóstico por imagem , Pele/efeitos dos fármacos , Resultado do Tratamento , Ácido Tricloroacético/administração & dosagem , Ácido Tricloroacético/efeitos adversos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA